The Valley Desk

ArticleClinical genitourinary cancerPublished

Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder Cancer

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Temple University, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical genitourinary cancer
Published
Subject terms
Humans; Neoplasm Metastasis; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Retrospective Studies; Quality of Life; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
41904052
Added to directory
Source checked

Report a correction or request removal